Can This New Test Find Cancer Faster Than Ever?Discover the future of cancer treatment on MedHeads! Dr. Ferghal Armstrong and Mohan Uttawar, CEO of One Cell Ai, unveil how liquid biopsies and single cell technology are transforming oncology. This breakthrough in biology uses liquid biopsy to detect circulating tumour cells (CTCs) via a simple blood test, revolutionizing precision medicine.

Mohan’s journey from an Indian village to Silicon Valley fuels his mission to advance cancer care through cell isolation and cell biology. His company’s medical research tools leverage single cell technology to analyze 100x more data, enabling earlier cancer detection and personalized cancer treatment. Dive into life sciences innovations like digital pathology, AI-driven research, and biomarker-based therapies that make cancer a manageable disease.

This episode explores circulating tumour cells, precision medicine, and future oncology trends, offering hope for patients and insights for medical professionals. Whether you’re a biotech enthusiast or caregiver, this research-packed discussion inspires!

Subscribe for more life sciences breakthroughs!

Share your thoughts below!

#LiquidBiopsies #CancerTreatment #PrecisionMedicine #SingleCellTechnology

Chapters

00:00 From Farming to MedTech Entrepreneur

05:39 Cancer, Immunity, and Genomic Variability

07:00 Transcriptomics: Gene to Protein Insight

10:28 Advancements in Circulating Tumor Cells

15:33 Cancer Treatment Monitoring Thresholds

16:39 CTC Monitoring in Cancer Care

20:51 Global Launch of Medical Technology

23:48 Hope for Managing Chronic Diseases